Copyright
©The Author(s) 2016.
World J Gastroenterol. Feb 14, 2016; 22(6): 2060-2070
Published online Feb 14, 2016. doi: 10.3748/wjg.v22.i6.2060
Published online Feb 14, 2016. doi: 10.3748/wjg.v22.i6.2060
Table 1 Validated target genes of hsa-miR-29c and hsa-miR-135b according to the miRTarBase database
MicroRNA | Target genes | Ref. Seq. RNA | Validation methods | No. of papers | ||||
Reporter assay | Western blot | qPCR | Microarray | Other | ||||
hsa-miR-29c | DNMT3A | NM_022552 | × | × | × | × | × | 3 |
NM_153759 | ||||||||
NM_175629 | ||||||||
NM_175630 | ||||||||
hsa-miR-135b | APC | NM_000038 | × | × | × | 1 | ||
NM_001127510 | ||||||||
NM_001127511 | ||||||||
KLF4 | NM_004235 | × | × | × | × | 1 |
- Citation: Vidal AF, Cruz AM, Magalhães L, Pereira AL, Anaissi AK, Alves NC, Albuquerque PJ, Burbano RM, Demachki S, Ribeiro-dos-Santos Â. hsa-miR-29c and hsa-miR-135b differential expression as potential biomarker of gastric carcinogenesis. World J Gastroenterol 2016; 22(6): 2060-2070
- URL: https://www.wjgnet.com/1007-9327/full/v22/i6/2060.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i6.2060